genedrive plc (AIM:GDR)
London · Delayed Price · Currency is GBP · Price in GBX 1.044
+0.194 (22.82%)
Oct 31, 2025, 4:35 PM GMT+1
genedrive Market Cap
genedrive has a market cap or net worth of 10.7 million as of October 31, 2025. Its market cap has decreased by -19.59% in one year.
Market Cap
10.70M
Enterprise Value
8.60M
Revenue
613.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.04
Market Cap Chart
Since April 10, 2007, genedrive's market cap has decreased from 11.67M to 10.70M, a decrease of -8.32%. That is a compound annual growth rate of -0.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 10.70M | -19.59% |
| Dec 31, 2024 | 13.31M | 33.76% |
| Dec 29, 2023 | 9.95M | -2.27% |
| Dec 30, 2022 | 10.18M | -74.34% |
| Dec 31, 2021 | 39.68M | 29.49% |
| Dec 31, 2020 | 30.64M | 290.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.55B |
| GSK plc | 71.55B |
| Haleon | 31.54B |
| Smith & Nephew | 11.59B |
| ConvaTec Group | 4.82B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 1.88B |
| Genus | 1.65B |